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ABSTRACT 
 
There is a need to understand the nature of aggregation of cyclodextrins (CDs) with guest 
molecules in increasingly complex formulation systems.  To this end an innovative 
application of Taylor dispersion analysis (TDA) and comparison with dynamic light 
scattering (DLS) have been carried out to probe the nature of ICT01-2588 (ICT-2588), a 
novel tumor-targeted vascular disrupting agent, in solvents including a potential buffered 
formulation containing 10% hydroxypropyl--cyclodextrin. The two hydrodynamic sizing 
techniques give measurement responses are that fundamentally different for aggregated 
solutions containing the target molecule, and the benefits of using TDA in conjunction with 
DLS are that systems are characterised through measurement of both mass- and z-average 
hydrodynamic radii. Whereas DLS measurements primarily resolve the large aggregates of 
ICT01-2588 in its formulation medium, methodology for TDA is described to determine the 
size and notably to quantify the proportion of monomers in the presence of large aggregates, 
and at the same time measure the formulation viscosity. Interestingly TDA and DLS have 
also distinguished between aggregate profiles formed using HP--CD samples from different 
suppliers. The approach is expected to be widely applicable to this important class of drug 
formulations where drug solubility is enhanced by cyclodextrin and other excipients. 
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1. Introduction 
 
 An understanding of the self-association behaviour and conformation change of a 
candidate drug in different environments is desirable towards its pharmaceutical 
development.  Insight into drug-excipient interaction behaviour is also required.  Rapid, cost-
effective techniques using small amounts or volumes of sample that can analyse a drug in a 
label-free and immobiliser-free solution are of high interest. It is also desirable to be able to 
rapidly screen a range of formulation buffers and characterise the increasingly complex 
formulations that are required to enhance solubility without the need for dilution.  Size-based 
analysis and viscosity measurements are key parameters required in the early assessment of 
parenteral drugs with potential for aggregate formation. Taylor dispersion analysis (TDA) is a 
technique for measurement of diffusion coefficient and hydrodynamic radius, named after Sir 
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Geoffrey Taylor who developed and provided the first practical test of the theory (Taylor, 
1953). There is a considerable body of literature on methodology and applications of TDA, as 
exemplified for single component systems
 
(Wakeham et al., 1976; Bello et al., 1994; Sharma 
et al., 2005; Cottet et al., 2007; d’Orlyé et al, 2008; Ribeiro et al., 2008)  and mixtures (Kelly 
and Leaist, 2004; Cottet et al, 2007, 2010). An instrument utilizing UV imaging detection at 
two windows for samples flowing through a capillary has been developed specifically for 
TDA and complementary solution viscosity measurements, and applied for characterising 
proteins and their formulations (Hawe et al., 2011; Hulse and Forbes, 2011a, 2011b). Very 
high precision (RSD < 1%) is obtained in protein sizing (Paraytec, 2010; Hulse and Forbes 
2011b; Hulse et al., 2013). Use of methodology with two windows has the benefit that 
contributions to variance other than Taylor dispersion, e.g. those from injection, are 
automatically removed (Chamieh and Cottet, 2012; Ye et al., 2012; Hulse et al., 2013). The 
instrument has recently been used as an early developability screen of therapeutic antibody 
candidates (Lavoisier and Schlaeppi, 2015). The authors noted that the instrumental 
combination of hydrodynamic radius measurements from nanolitre quantities with solution 
viscosity measurements allowed screening of candidates with a view to the early 
identification of candidates with development issues.   
 A number of solubilisation strategies can be used to enhance the solubility of poorly 
soluble drugs (Douroumis and Fahr, 2013). For anti-cancer candidate drugs a range of 
technologies have been trialled for targetting and/or solubilisation purposes.  These include 
the use of liposomes (Deshpande et al., 2013), polymer micelles (Richter et al., 2010),
 
dendrimers (Svenson and Chauhan, 2008), and cyclodextrins (Gidwani and Vyas, 2015). 
Cyclodextrins are often used to increase drug solubility through complex formation (Uekama 
et al., 1998). The ability of cyclodextrins to self-associate and the role of cyclodextrin-drug 
complexes and aggregates in solubilisation and delivery of drugs have been well documented 
in a series of papers by Loftsson and coworkers amongst others (Loftsson and Brewster, 
1996, 2012; Loftsson et al., 2002, 2004; Messner et al., 2010, 2011; Jansook et al., 2010; 
Loftsson, 2014). The body of work showed that solubilisation and stabilisation of drugs in 
aqueous CD formulations are strongly influenced by other commonly used excipients.  
Jansook et al. (2010) were able to conclude that CD solubilisation is also affected in 
combination formulations containing more than one drug and that CD formulation studies 
should always be performed in a medium that closely resembles the final drug formulation. 
 Given that subtle changes in the formulation buffer composition can affect 
solubilisation and aggregate formation, and that inclusion complexes as well as a range of 
sizes of aggregates can be present in aqueous complexation media, and that such 
compositions are concentration dependent (Messner et al., 2010), there is a need for 
analytical tools to characterise such systems and provide formulation fingerprints. Valente 
and Soderman (2014) affirm this view by pointing out that CD self-assembly is a 
fundamental issue that remains veiled or not completely clear in this promising field with 
plenty of challenges.  
 Physico-chemical methods used to characterise binding and aggregation in such 
systems include dynamic light scattering (DLS) and NMR. The use of microscopy in this 
field has been reviewed (He et al., 2008). Messner et al. (2010) highlighted some of the 
deficiencies of the various instruments including that NMR results can be difficult to 
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interpret, especially when numerous atomic interactions are being investigated. When 
recently applied to the study of whether native cyclodextrins aggregate in water, three 
1
H 
NMR techniques (NMR diffusometry, relaxometry, and proton peak intensity) showed that 
levels of large aggregates (> 100 CDs) were below the detection limit of 1% (Valente et al., 
2015). Regarding DLS measurements, it has been commented that Rh is obtained but not 
shape, it can be difficult to find acceptable laser intensity that produces reliable results, and 
concentrated solutions produce signal noise (Messner et al., 2010). From the above it is clear 
that a range of techniques and new tools are helpful in characterising such complexity.  
 TDA has been used to measure diffusion coefficients and hydrodynamic radii of 
cyclodextrins (Ribeiro et al., 2007, 2008). TDA methodology can also provide information on 
binding of guest molecules. With UV absorbing guest species and spectrophotometric 
detection,  the diffusion constants of guest molecules have been investigated as a function of 
cyclodextrin concentration and binding curves obtained (De Azevedo et al., 2000) from 
which binding constants can be determined  (Bielejewska et al., 2010; Jensen and Østergaard, 
2010). Another approach has been to use a differential refractometer to measure mutual 
diffusion coefficients over a range of guest and host concentrations and fit these data (Barros 
et al., 2015; Filho et al., 2016). 
  Whilst binding can be studied in favourable cases, there have been no approaches 
using TDA to look at aggregation of cyclodextrin complexes. Addressing this challenge, the 
objective of the present work is to explore the use of a different methodological approach for 
TDA, alongside DLS, to provide mechanistic insight towards the nature of the solubilisation 
strategy for a poorly soluble drug candidate, and the aggregation behaviour of drug-CD 
complexes.  
 
Insert Fig. 1 here 
 
 ICT01-2588 (Figure 1), originally referred to as ICT2588 (Gill et al., 2008), is a novel 
tumor-targeted vascular disrupting agent activated by membrane-type matrix 
metalloproteinases (Atkinson et al., 2010; Ansar et al., 2014) which has demonstrated pre-
clinical therapeutic activity against solid tumors and reduced potential for cardiovascular 
toxicity (Gill et al., 2014). In this paper we report results of TDA experiments on ICT01-2588 
in the solvents dimethylsulfoxide (DMSO), methanol, and TDA alongside complementary 
DLS studies in a potential formulation medium Tris buffer containing 10% hydroxypropyl--
cyclodextrin. 
 
 
 
 
 
2. Materials and methods 
 
2.1. Materials 
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 ICT01-2588 was provided by Incanthera Ltd (Bradford, UK). Methanol and dimethyl 
sulfoxide were purchased from Fisher Scientific UK Ltd (Loughborough, UK).  Tris 
(tris(hydroxymethyl)aminomethane) and its hydrochloride salt (Trizma-base, Trizma-
hydrochloride), fluorescein disodium salt, Hellmanex III and a first sample of (2-
hydroxypropyl)-β-cyclodextrin (HP--CD), product code H107, were purchased from Sigma-
Aldrich Ltd (Poole, UK). This first sample of HP--CD was specified to have degree of 
substitution of 2-hydroxypropyl units 0.5-1.3 per glucose unit and in this paper is referred to 
as HP--CD-s1. A second sample of HP--CD, product code 1038870, was obtained from 
Fisher Scientific Ltd (Loughborough, UK). This has specified degree of substitution of 2-
hydroxypropyl units 2-6, i.e. 0.3-1.0 per anhydroglucopyranose (glucose) unit, and is referred 
to as HP--CD-s2. 
 
2.2. Sample preparation 
 
 ICT01-2588 was dissolved in methanol at 0.5 mg/mL, and a series of two-fold 
dilutions were made to 0.03125 mg/mL. ICT01-2588 was dissolved in DMSO at 1 mg/mL, 
and subsequent two-fold dilutions made to 0.0625 mg/mL. All solutions were freshly 
prepared prior to analysis using the Viscosizer 200.  
 Tris buffers were directly prepared to nominal pH 8.40, by dissolving the appropriate 
amount of Trizma-HCl (264 mg) and Trizma-base (403 mg) in 100 mL distilled water. HP--
CD was dissolved in Tris buffer (pH 8.40) to 0.10 g/mL. 5.0 mg of ICT01-2588 were 
dissolved by stirring overnight in 2 mL of the 0.1 g/mL HP--CD Tris buffer (pH 8.40), 
giving a stock solution of concentration 2.5 mg/mL. Samples of ICT01-2588 each with total 
volume 400 L were prepared from this stock solution directly into the vials of the Viscosizer 
200 autosampler by mixing V L stock and (400-V) L 0.1 g/mL HP--CD Tris buffer. With 
V = 400, 320, 160, 80 and 40 L, concentrations were 2.5, 2.0, 1.0, 0.5 and 0.25 mg/mL, 
respectively. Samples of fluorescein disodium salt were prepared at mass concentrations 0.44, 
0.35 and 0.17 mg/mL in Tris buffer and Tris buffer with 0.1 g/mL HP--CD. 
   
2.3. Taylor Dispersion Analysis 
 
2.3.1. Instrumentation 
 Instrumentation used was a Viscosizer 200 (Malvern Instruments, Malvern, UK), with 
a fused silica capillary 75 m ID, 360 m OD, total length 130 cm, lengths to the end of 
window 1 and window 2 45 cm and 85 cm, respectively. The temperature for the 
measurements was set at 25.0
o
C. Each series of runs was carried out with light selected using 
an optical filter at either 280 or 490 nm. Stray light corrections were automatically made in 
software after initial measurements with the appropriate stray light test solution (4-
hydroxybenzoic acid 10 mg/mL in 0.1 M NaOH for 280 nm; fluorescein disodium salt 10 
mg/mL in water for 490 nm).  
 
2.3.2. Measurement of hydrodynamic radius 
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 The pulse injection mode was used for sizing (see Supplementary Information, Figure 
S1). Sequences for the runs are given in Table 1.   
 
Insert Table 1 here 
 
Absorbance versus time data are automatically processed to obtain the diffusion coefficient, 
D, and hydrodynamic radius, Rh.  
  The software determines peak centre times at the first and second window, t1 and t2 
respectively, and the corresponding standard deviations, 1
 
and 2, and variances, 1
2 
and 2
2
. 
Variances and times are used to calculate D and Rh, using Eqs. 1, 2 and 3. 
 
2
2
 – 1
2
 = r
2
(t2 – t1)/24D          (1) 
 
D = kBT/6Rh          (2)
        
Rh = 4kBT(2
2
 – 1
2
)/r2(t2 – t1))        (3)
  
where kB is the Boltzmann constant, T the absolute temperature,  the viscosity of the 
solution, and r the capillary radius.  
 
2.3.3. Measurement of viscosity 
 Time difference data obtained in the pulse injection mode sizing experiments also 
allow measurement of relative viscosity, since the capillary with two windows serves as a 
capillary viscometer (Tanford, 1961; Paraytec, 2011; Ye et al., 2012).
 Poiseuille’s law for the 
velocity of pressure-driven flow in a tube shows that
 
 
v = x/t = r2P/8L          (4) 
           
where v is the velocity, x the distance and t = t2 - t1 the time difference between the two 
windows, P the pressure, and L the length of the capillary. It is evident from Eq. (4) that if 
all other variables are constant, the time difference is directly proportional to the viscosity. 
 In the case where carrier solution and sample are prepared in the same solvent and a 
reference solution is run under the same pressure drive conditions 
 
/o = rel = t/to          (5) 
 
where o is the viscosity of the reference solution,  the viscosity of the solvent and rel is the 
relative viscosity. Runs with the reference solution (water containing trace amounts of 
caffeine) were typically carried out immediately before the sizing runs. This approach was 
used for confirmation of the viscosity of the solvents (methanol, DMSO) by comparison with 
literature values at the temperature of the measurements (25.0
o
C). It was also used for 
determination of the viscosity of the potential formulation medium, Tris buffer containing 
10% HP--CD. 
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2.3.4. Capillary wash protocols 
 When using solutions containing HP--CD, where samples contained aggregates and 
problems with capillary blockage were noted in initial test experiments, a wash protocol 
using nitric acid and DMSO as reagents to remove any surface-adsorbed species and 
aggregates was used prior to each run sequence. During the final phase of these experiments, 
using fluorescein disodium salt as sample, an alternative capillary washing protocol was 
tested and found to give excellent results, so is detailed here. This involves the reagent 
Hellmanex III, which is widely used to clean fused silica spectrophotometer cells. At the 
beginning of the experiment, rinse with Hellmanex III (2% v/v) at 2000 mbar for 45 min 
followed by a wash with water for 15 min at 2000 mbar. Between the runs for different 
concentrations in the series, rinse with Hellmanex III (2% v/v) at 2000 mbar for 5 min 
followed by a wash with water at 2000 mbar for 5 min.  
 
2.4. Dynamic Light Scattering 
 
 Dynamic light scattering experiments were carried out using a Zetasizer Nano ZS 
(Malvern Instruments Ltd., Worcestershire, UK; laser wavelength 633 nm). Samples were 
analysed unfiltered. Appropriate detector settings were automatically determined by the 
instrument and three replicate measurements for each sample were performed at 25
o
C after an 
equilibration period of 10 minutes. The DLS instrument measures mutual diffusion 
coefficients, and hydrodynamic radii were derived from these using absolute viscosity values 
(c.f. equation 2) determined by the Viscosizer 200 as documented above. When calculating 
the volume average radius for HP--CD in Tris buffer, refractive index values used were 
1.330 for the dispersant and 1.570 for the material. 
 
 
3. Results and discussion 
 
3.1. ICT01-2588 in DMSO and methanol 
 
 3.1.1. Sizing from Taylor Dispersion Analysis 
 Sizing runs were carried out in DMSO and methanol at 280 nm. Because of the 
differences in viscosity of the two solvents, the drive pressure was decreased from 140 mbar 
with DMSO to 70 bar with methanol to provide better comparability of run times. Examples 
are shown in Figure 2. At concentrations below 0.25 mg/mL in DMSO, and 0.125 mg/mL in 
methanol, the peaks were found to have anomalous profiles: this was attributed to a refractive 
index artefact from slight mismatch of solvent levels in sample and carrier media, which has 
greater effect the smaller the peak.  
 
Insert Fig. 2 here. 
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 Results for fitting Gaussian peak profiles to give hydrodynamic radius, as described in 
the Experimental section, are summarized in Table 2. The literature values for the viscosity 
(0.544 mPa s for methanol, Xiang et al., 2006), 1.992 mPa s for DMSO (Ciocirlan and Julian, 
2009) were used in calculation of hydrodynamic radii using equation (3). The measured 
difference in time between the two windows, relative to that for the reference solution water 
containing a trace of caffeine (see Eq. (5), gave viscosities for ICT01-25588 in methanol 
0.530 ± 0.007 mPa s (n=20) and in DMSO 2.025 ± 0.023 mPa s (n=10), in satisfactory 
agreement with the literature values.  
 For DMSO, relative standard deviations in the hydrodynamic radius within a set of 5 
replicate runs are less than 2% at the two highest concentrations, but increase on decreasing 
the concentration as the peak amplitudes become smaller. There is no evidence for any trend 
in variation of radius with concentration, and this suggests that ICT01-2588 is present as a 
monomeric species in DMSO. The average of all radii in DMSO is 1.23±0.06 nm. 
 In methanol, whilst values of the radius at two concentrations seem slightly lower 
than those in DMSO, the average of all radii 1.14±0.13 nm is within the range of uncertainty 
not significantly different from the value in DMSO.  
 In previous work (Ansari et al, 2014), molecular modeling of the linker in ICT01-
2588, defined as the peptide sequence with the N-terminal masking group containing 
fluorescein isothiocyanate (i.e. everything aside from the C-terminal colchicine group in Fig. 
1), gave length 2.6 nm. This is consistent with radius 1.1-1.2 nm observed for ICT01-2588 by 
the present TDA sizing study.  
 Gaussian peak profile fitting also gives data for peak areas. Peak area measurements 
are of relevance in checking for self-consistency, that the amount of sample seen at the two 
windows is the same as the amount injected, and that there is no loss e.g. due to adsorption on 
the walls. To address the fact that there has been no formal treatment of this in any previous 
papers on TDA, theory linking peak area with injection time, sample concentration and 
absorption coefficient is presented in the supplementary information. The methodology was 
used to compare areas for ICT01-2588 in experiments at the same wavelength, 280 nm, in 
DMSO, methanol, and Tris buffer containing 10% HP--CD. Self-consistency was 
demonstrated across the solvent media, and the absorption coefficient at 280 nm (Table S1) 
shown to accord with the sum of the absorption coefficients of the functional groups (Table 
S2).  
 It should be noted that at all concentrations studied ICT01-2588 is below its solubility 
limit, which in methanol is ~ 0.6 mg/mL. The solubility of ICT01-2588 in water is approx. 15 
g/mL, as estimated from area under the curve from HPLC data fitted to a standard curve. 
 
Insert Table 2 here 
 
3.2. ICT01-2588 and fluorescein in Tris buffer with 10% HP--CD 
 
3.2.1. Solubilisation of ICT01-2588 
 ICT01-2588 has very limited solubility in water and aqueous buffer solutions. A 
potential formulation medium under exploration is a pH 8.4 Tris buffer with 10% HP--CD.  
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A photograph of samples of ICT01-2588 at nominal concentration 1 mg/mL in this medium, 
prepared with HP--CD-s2, and in water and in Tris buffer is shown in Fig. 3.  Little of the 
ICT01-2588 sample is seen to have dissolved in water, whereas the material is fully 
solubilised at concentration 1 mg/mL in the Tris buffer with 10% HP--CD and has the 
characteristic colour and tint of the chromophoric fluorescein end group in the structure (Fig. 
1). 
 
Insert Fig. 3 here 
 
3.2.2. Taylor Dispersion Analysis profiles for ICT01-2588 
 TDA runs were carried out at a range of concentrations using the protocols for sizing 
as shown in Table 1. Fig. 4a illustrates sizing records from one run sequence over the range 
0.25 to 2.5 mg/mL ICT01-2588 in pH 8.4 Tris buffer with 10% of the HP--CD-s1. It is 
evident that the TDA results are qualitatively completely different from those when the 
compound is prepared in methanol or DMSO (Fig. 2). As the concentration increases, a 
component which has a front running at twice the velocity of the central peak and slowly 
decays with time increasingly dominates the profile of absorbance versus time. This is 
characteristic of a relatively large species with sub-micron particle size which has zero 
diffusion on the timescale of the experiment (Taylor, 1953; Latunde-Dada et al., 2015). 
Latunde-Dada et al. (2015) exemplified the transition between pure convection and early time 
dispersion using a series of polystyrene latex standards with Rh 100, 200 and 300 nm in 
experiments on the Viscosizer 200 instrument. A predominantly convective profile was 
observed for the 200 nm standard at a run pressure of 250 mbar, with the front arriving at 
window 1 at 100 s, whilst at 18 mbar pressure a normal TDA Gaussian profile was obtained. 
The run pressure for transition between pure convection and early time dispersion profiles 
scales inversely with hydrodynamic radius.  
 At 0.25 mg/mL the peaks similar to those of monomer are seen as the dominant 
feature at the two windows. At 2.5 mg/mL, at the first window the front has higher amplitude 
than the Gaussian type peak. There is very good reproducibility of all of the profiles from the 
set of 5 replicates (see supplementary information, Fig. S2). From comparison of the results 
at all 5 concentrations studied, 0.25, 0.5, 1,with the front arriving 2 and 2.5 mg/mL, the area 
at window 1 of the Gaussian peak is seen to remain qualitatively constant whilst the 
amplitude of the front increases systematically with increasing concentration. 
 
Insert Fig. 4 here 
 
 When runs were carried out using the second HP--CD sample, HP--CD-s2, for 
sample formulation and as the carrier liquid in the sizing experiments, significant differences 
in behaviour were observed by comparison with the first HP--CD sample, HP--CD-s1. 
Runs in pH 8.4 Tris buffer with 10% of the HP--CD-s2 were carried out at two wavelengths, 
280 and 490 nm, and the same behaviour was observed at both wavelengths.Fig. 4b shows 
concentration dependence at the 5 concentrations 0.25, 0.5, 1. 2 and 2.6 mg/mL and the 
results of 5 replicate experiments. At 2.5 mg/mL, at the first window the front has much 
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lower amplitude than the Gaussian type peak. The amplitudes of both the front and the 
Gaussian peak increase with increasing ICT01-2588 concentration.  
 
3.2.3. Viscosity of the formulation medium 
 For determining viscosity, required to make the conversion from diffusion coefficient 
to hydrodynamic radius (c.f. Eqs. (1) and (2)), the time difference between the centre of the 
narrow peak ascribed to non-aggregated species was compared to that for runs with water 
containing trace amounts of caffeine carried out immediately before or after the sequence, as 
described in Eq. (5). From all of the runs with 10% HP--CD-s1, there was extremely high 
reproducibility in the time difference, and the viscosity was determined to be 1.301±0.028 
mPa s. From all the runs with HP--CD-s2, the viscosity was determined to be 1.301±0.035. 
The fact that both values are identical shows that there is no difference between the the two 
HP--CD samples with regard to viscosity.  
 
3.2.4. Hydrodynamic radius and percentage of non-aggregated form of ICT01-2588 
 Data fitting was carried out using theory for convective diffusion (Latunde-Dada et 
al., 2015). An example is shown in Fig. 5.  
 
Insert Fig. 5 here  
 
 Table 3 collects together the quantitative findings from Taylor dispersion analysis and 
convective diffusion theory for 125 runs, giving the hydrodynamic radius and percentage of 
the non-aggregated form of ICT01-2588. Results for % area are given for window 1. As 
previously discussed from qualitative inspection of the traces, the first HP--CD sample, HP-
-CD-s1 has different behaviour from the second sample, HP--CD-s2. For HP--CD-s1, the 
peak area of the non-aggregated form increases by only a factor 2 over the 10 fold range of 
concentration 0.25-2.5 mg/mL. This means that its percentage of the total area systematically 
decreases as the concentration of ICT01-2588 increases, from 79 to 14% in going from 0.25 
to 2.5 mg/mL. By contrast, with HP--CD-s2 the percentage area for the non-aggregated 
form of ICT01-2588 is between 58 and 100% at 0.25 mg/mL, and is also high at the highest 
concentrations, being in the range 72-81% at 2 and 2.5 mg/mL for the 1
st
, 2
nd
 and 3
rd
 run 
sequence. Unlike all the other sequences, where the runs were carried out from low to high 
concentration and typically spanned a total time of … hours, the 4th sequence had 
measurements taken from high to low concentration over this time duration, and there 
appeared to be rather low percentages of the non-aggregated form in the high concentration 
runs at the beginning of the sequence. 
 
Insert Table 3 here 
 
 Hydrodynamic radius values are all within a narrow range, 1.27 – 1.42 nm, for the 
non-aggregated form measured in HP--CD-s2 at the two highest concentrations in the 1st, 
2
nd
 and 3
rd
 run sequences. There is also broad consistency across all runs with both HP--CD-
s1 and HP--CD-s2, with radius in the range 1.27-1.92 nm for all measurements where the 
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percentage of non-aggregated form was in excess of 50%. The average of all radii for ICT01-
2588 in HP--CD-s2 where the non-aggregated form is >50% of the total is 1.32±0.07 nm. 
This is somewhat higher than the average radius 1.19±0.10 nm in DMSO and methanol 
(Table 1). Since ICT01-2588 is present as a monomer in these solvents, results are consistent 
with the non-aggregated form of ICT01-2588 also being a monomer in HP--CD, though 
with complexation to HP--CD causing a slight addition to the radius. Analogous findings 
are reported for fluorescein in HP--CD later in this section, and further discussion will be 
presented in the section dealing with the nature of the aggregation. 
 From the entries in Table 3, for both forms of HP--CD where the percentage of non-
aggregated form of ICT01-2588 is < 50%, there is seen to be a general increase in average 
radius with decrease in % non-aggregated form. With % non-aggregated form given in square 
brackets, values of average radius are 2.2-2.9 nm [49-40%], 3.2-3.6 nm [39-30%], 6.8 nm 
[29-20%], 4.6-5.0 nm [19-10%].  
 This increase in radius could be in part due to time-dependent changes during travel 
between the two windows. For runs with significant levels of aggregate, data fitting using 
convective diffusion theory with a single monomer component results in good fitting at 
window 1, but the fitting at window 2 is less satisfactory (see e.g. Fig. 5). Also, the area for 
the non-aggregated form increases between the two windows. These observations in the 2 
window TDA measurements could be indicative of kinetic effects, moving the system to 
rebalancing the monomer-aggregate equilibrium position during pressure-driven flow in the 
capillary. The aggregate, driven purely by convective flow, is distributed over a far greater 
length of the capillary than the monomer, where Taylor dispersion ensures that the species 
occupies a fairly narrow zone. A schematic diagram, illustrating the conditions in Fig. 5,  is 
given in Figure 6. The mixture injected has 80% aggregate, A, and 20% monomer, M. The 
front of the aggregate distribution travels at twice the velocity of the average of the flow and 
monomer peak, and has a concentration profile in space retaining the triangular shape and 
time profile of the injection zone at the front and then tracking back to zero in a linear fashion 
as distance decreases. The monomer has a Gaussian profile centred at 45 cm when it reaches 
window 1, and this broadens by further Taylor dispersion corresponding to window 2 centred 
at 85 cm. At this point the front of the aggregate profile has already exited the 130 cm 
capillary. The relative concentrations of aggregate and monomer can be seen at all distances, 
and  it is evident that M/A > 1 at the maxima but M/A = 0 outside the Gaussian bands. This 
imbalance relative to the starting relative concentrations M/A = 20/80 is suggested as the 
driver for rebalancing the monomer-aggregate equilibrium, with the greater time to window 2 
than to window 1 allowing more time for reequilibration which distorts the observed peak 
profile as seen in Fig. 6 away from the ideal of Fig. 5. If aggregate size steadily decreases 
during reequilibration, the larger size of the aggregate for ICT01-2588 in HP--CD-s1 than in 
HP--CD-s2 (see DLS results in subsequent section, 3.2.6) could be consistent with 
differences between the two cyclodextrins seen in the TDA experiments, since a minimum 
hydrodynamic radius of ~100 nm is needed for a convective diffusion profile under the 
conditions of Fig. 5.  
 
Insert Fig. 6 here 
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3.2.5. Hydrodynamic radius for fluorescein in Tris buffer and Tris buffer with 10% HP--CD 
 Noting references to self-aggregation of cyclodextrins (Loftsson and Brewster, 1996, 
2012; Loftsson et al., 2002, 2004; Messner et al., 2010, 2011; Jansook et al., 2010; Loftsson, 
2014; He et al. 2008), sizing experiments were carried out with fluorescein in the same 
carrier medium as that for ICT01-2588, pH 8.4 Tris buffer with 10% HP--CD-s2, and also 
in the Tris buffer without any added cyclodextrin. Fluorescein, conjugated to the peptide 
sequence via an isothiocyanate linker, is one of the functional end groups of ICT01-2588 (see 
Fig. 1). Mass concentrations of fluorescein disodium salt (0.44, 0.35, 0.17 mg/mL) were 
chosen to give molar concentrations similar to those for ICT01-2588 at the three highest 
concentrations (2.5, 2.0 and 1.0 mg/mL), and wavelengths used were 280 or 490 nm. There 
was no evidence from the Taylor dispersion profiles for any aggregation, and a single-
component Gaussian fitted well to all observed profiles.  
 All hydrodynamic radius measurements for fluorescein disodium salt in Tris buffer 
and Tris buffer with 10% HP--CD is presented in the Appendix, Table S3. From the results 
in Tris buffer, TDA was found to give hydrodynamic radius with excellent reproducibility 
(all RSDs less than 2%). As expected, there was no dependence on detection wavelength, 
with values for Rh measured at 280 and 490 nm, 0.531 ± 0.007 nm and 0.527 ± 0.006 nm 
respectively, the same within the error limits. There was also no dependence on 
concentration. The viscosity value for water, 0.8905 mPa s, was the input value for the 
calculations using Eq. (3).   
 From the time difference between the two windows in the Tris buffer with 10% HP--
CD-s2, the viscosity (1.30 mPa s) was found to be identical to that measured in the 
experiments with ICT01-2588 (1.301 mPa s, see section 3.2.3), and this value was used in the 
calculations for Rh (Eq. (3)) in this carrier medium. The average hydrodynamic radius 
obtained for fluorescein in Tris buffer with 10% HP--CD from these TDA experiments over 
the three concentrations was 0.825 ± 0.028 nm. This Rh value is substantially greater than for 
fluorescein in Tris buffer, 0.529 ± 0.006 nm, and also greater than the value of 0.76 nm for 
the hydrodynamic radius of HP--CD in water (Ribeiro et al., 2007). The 56% increase in 
effective radius for fluorescein is consistent with binding to HP--CD in a host-guest 
complex, as discussed in a subsequent part of this paper (section 3.3). 
 Unlike in section 3.2.4 where TDA gives definitive evidence for aggregation of 
ICT01-2588 in Tris buffer with 10% HP--CD, there is no evidence from any of the 
Taylorgrams or TDA experiments reported in this section that fluorescein by itself is present 
in an aggregate or promotes self-aggregation of the cyclodextrin. 
 
3.2.6. Dynamic Light Scattering for ICT01-2588 in Tris buffer with 10% HP--CD 
 Dynamic light scattering measurements were made on ICT01-2588 at concentration 
2.5 mg/mL in Tris buffer with 10% HP--CD-s1, the first HP--CD sample. Subsequently a 
more extensive series of measurements was carried out using the second HP--CD sample. 
Solutions of ICT01-2588 at two concentrations 2.5 and 0.25 mg/mL were characterised in 
Tris buffer with 10% HP--CD-s2. Reference measurements were made at the same time on 
the buffer with 10% HP--CD-s2. Results are given in Fig. 7 and Table 4.  
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Insert Fig. 7 here 
 
Insert Table 4 here 
 
 A qualitative comparison from Fig. 7 shows that ICT01-2588 has higher z-average 
radius in HP--CD-s1 than in HP--CD-s2, and that there is no contribution from any non-
aggregated species to the z-average intensity distribution for either sample. Quantitatively, 
results in Table 4 show that the z-average radius for 2.5 mg/mL ICT01-2588 in HP--CD-s1 
is a factor 5 greater than that in HP--CD-s2, 728 nm vs. 144 nm. There is no change in 
radius with concentration in going from 2.5 to 0.25 mg/mL.  
 There is no suggestion of any non-aggregated species in these DLS data for ICT01-
2588, despite the fact that the TDA sizing results discussed in section 3.2.4 show substantial 
proportions of monomeric ICT01-2588 in equilibrium with the aggregate.   
 The explanation for the different results from the two techniques is that DLS reports 
intensity-weighted size distributions, whereas mass-weighted size distributions are obtained 
from TDA. Because scattering intensity typically scales with the sixth power of radius 
Malvern Instruments, 2011), high radius species are extremely strongly weighted in DLS.  
 It is only in the case of the reference measurements on the solvent, Tris buffer with 
10% HP--CD-s2, that a substantial proportion (42%) of a low radius species (0.72 nm) is 
present in the intensity distribution. The size distribution by volume gives 100% of the low 
radius species, with volume mean hydrodynamic radius 0.67 nm. These hydrodynamic radii 
from DLS provide a satisfactory match to the literature value of 0.76 nm (Ribeiro et al, 2007) 
for the molecule present in highest concentration, HP--CD. 
 Dynamic light scattering measurements were also made for fluorescein in the same 
solvent, Tris buffer with 10% HP--CD-s2. The z-average radius was 187 nm, and there was 
a small proportion (18%) of a low radius species (0.72 nm). By contrast, as discussed in 
section 3.2.5, TDA gave 100% of the low radius species (0.825 nm), and this mass-weighted 
distribution gave no evidence for any aggregates. This is an important point to note when 
using DLS to characterise aggregates in cyclodextrins, suggesting that DLS intensity 
measurements need to be complemented by other techniques (see e.g. He et al., 2008) to 
avoid overweighting the contributions of aggregates to the overall distributions. 
. 
3.3. Nature of aggregation 
 
3.3.1. ICT01-2588 binding to HP--CD  
 Taken together, the results from TDA and DLS suggest that in HP--CD there is a 
bimodal distribution between monomer and aggregate forms of ICT01-2588.  The monomer 
is likely to itself be a distribution over free- and cyclodextrin-bound species, since ICT01-
2588 has both end groups and side-chain groups in the linker which bind to cyclodextrins.  
 In this section, literature results on solubilisation and binding to cyclodextrins of 
individual groups in ICT01-2588 are considered and used to estimate fractions bound to HP-
β-CD. The five potential binding groups are indicated by arrows in Fig. 1. Phase-solubility 
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analysis has been carried out for colchicine binding to HP--CD, studying solubility as a 
function of cyclodextrin concentration over the range in phosphate buffered saline (pH 7.4) 
containing various concentrations of HP-β-CD (Mw~1600; 30–180 mM) based on the 
maximum solubility of HP-β-CD (50% w/v at 25°C) in water (Chauhan et al., 2013). 
Solubility was found to increase in a linear fashion, indicative of 1:1 binding classified as AL 
type according to nomenclature introduced by Higuchi and Connors (1965), and a binding 
constant, K, of 310 M
-1
 reported (Chauhan et al., 2013). Assuming no change to K when 
colchicine is the end group in the structure of Fig. 1, the fraction bound, fb, can be calculated 
using the equation  
 
fb = KC/(1+KC)                                                                                                                    (6) 
 
together with the value of the binding constant as above and the molar concentration C = 
7.2x10
-2
 M, which corresponds to HP--CD at mass concentration 10% w/v. This approach 
gives fb = 0.96 and suggests that the colchicine would be present mostly bound to 
cyclodextrin.  
Whilst no data are available for HP--CD solubilisation or binding for other groups in 
ICT01-2588, binding constants, K, with -CD have been documented for fluorescein, 360 M-
1
 (Flamigni, 1993), tyrosine, 48 M
-1
 (Bekos et al., 1996), phenylalanine, 85 M
-1
 (Kahle
 
and 
Holzgrabe, 2004) (no value available for homophenylalanine). Assuming K values for HP--
CD are similar to those for -CD, and comparability between groups either free or part of the 
ICT01-2588 sequence, estimates of the fractions bound can be made using Eq. (6). Values are 
fb > 0.8 for all groups considered individually, indicating that the proportion of cyclodextrin-
bound groups is always greater than the free proportion. For fluorescein, where fb = 0.96, the 
calculation is consistent with results reported in section 3.2.5, where the value of 
hydrodynamic radius of fluorescein in 10% w/v H--CD measured using TDA was shown to 
be far greater than that for free fluorescein. Other studies using TDA with UV detection to 
monitor drug binding to cyclodextrins (Bielejewska et al., 2010; Jensen and Østergaard, 
2010) offer similar conclusions. 
 Formulae for cases where drugs bind more than one cyclodextrin are given in papers 
by Loftsson et al. (2004) and Loftsson and Brewster (2012). Distribution calculations (data 
not shown) suggest that the highest fractions of the population of ICT01-2588 species involve 
multiple bound CDs, and may indicate that the hydrophilic, highly water soluble cyclodextrin 
HP--CD helps solubilise ICT01-2588 through binding to more than one of the end or side 
chain groups.  
 
3.3.2. Aggregation 
 The types of aggregation in cyclodextrin drug systems have been extensively 
researched and reviewed by Loftsson and his collaborators (Loftsson and Brewster, 1996, 
2012; Loftsson et al., 2002, 2004; Messner et al., 2010, 2011; Jansook et al., 2010; Loftsson, 
2014), Supramolecular assemblies of amphiphilic cyclodextrins alone or in self-assembled 
mixtures with other molecules of therapeutic significance are described in a recent review by 
Zerkoune et al. (2014). A bis-adamantine molecule which binds cyclodextrins at both ends 
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and forms a hydrophilic -cyclodextrin bis-inclusion complex has been shown to self-
assemble into supramolecular vesicles (Nayak and Gopidas, 2015).   
 For HP--CD-s1, our TDA experiments suggest a monomer-aggregate equilibrium 
with a fairly constant concentration of monomer accompanied by increasing levels of 
aggregate across the 10-fold increase of drug concentration. Monomer-aggregate equilibria 
with similar characteristics, where the monomer concentration is the critical aggregation 
concentration, are exemplified in work on liposomes and vesicles by Nardin et al. (2000) and 
Chécot et al. (2002).  
 For HP--CD-s2, aggregates are smaller in size than with HP--CD-s1 and 
proportions of ICT01-2588 monomer are high even at high total drug concentration.  
 Differences between the Taylor dispersion profiles (or Taylorgrams, Cottet et al., 
2010), of the two HP--CD samples may in part be due to one of them, HP--CD-s2, 
specified to contain levels of up to 3% -CD. There are also differences in the specified 
degree of substitution. -CD and HP--CD vary in their solubility and drug binding 
characteristics, and for HP--CD binding constants have also been noted to differ with 
changes in degree of substitution (Penn et al., 1994). The ability to rapidly obtain such 
Taylorgrams which can serve as “fingerprint’ characterisation of drug and CD aggregation 
states with formulation composition is useful in a quality by design approach to identifying 
product critical quality attributes.  
 In future work with ICT01-2588, it may be of interest to carry out systematic studies 
varying the cyclodextrin concentration, complementing TDA and DLS by using phase 
solubility methods to establish the concentration dependence of solubility to help establish 
the nature of the binding and the number of HP--CD molecules bound per ICT01-2588 unit.  
Other questions of interest concern time and shear dependence of the monomer-aggregate 
equilibrium: these dynamic factors are amenable to probing by TDA by varying the flow and 
shear rates. 
 
4. Conclusion 
 
The need for new analytical tools to deliver understanding of drug self-association and drug-
excipient interaction in complex media is of great interest towards producing quality 
pharmaceutical products.  Adding to our awareness of growing formulation complexity, 
literature in the last decade or so has moved our thinking from viewing CD complexation as a 
simple binding of a lipophilic drug moiety to a hydrophilic CD cavity to more complex 
models that can involve the self-association of CD molecules and CD complexes themselves.  
The findings we present highlight the ready use of TDA to explore the self-association of a 
peptide containing potential drug molecule in a range of solvents including a formulation 
where excipient association is possible. This study of a candidate drug molecule ICT01-2588 
has shown the benefits of using Taylor dispersion analysis in conjunction with dynamic light 
scattering to characterise systems through measurement of both mass- and z-average 
hydrodynamic radii. Both viscosity of the solvent or formulation medium and hydrodynamic 
radius of the candidate drug are determined. Crucially, TDA provides the unique ability to 
see and quantify the proportion of monomers in presence of large aggregates of ICT01-2588 
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in its formulation medium containing 10% HP--CD. This is not possible using DLS, where 
the aggregates dominate the scattering signal response. TDA and DLS have also allowed 
distinction between aggregates formed using HP--CD samples from different suppliers. The 
approach is expected to be of wide applicability to this important class of systems where drug 
solubility is enhanced by cyclodextrin and other excipients.  The ability to explore 
formulation design space of complex systems and progress rapid quality by design protocols 
is of great promise in helping us gain a clear view of these complex but highly useful 
systems.  
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Tables 
Table 1. Sequences for Viscosizer 200 runs  
Method Sequence Pressure 
(mbar) 
Time 
(min) 
Sizing Rinse (carrier) 2000 1 
 Fill (carrier) 2000 1 
 Reset Baseline 140 1 
 Load (sample) 50 or 140
a
 0.2 
 Dip (carrier) 0 0.15 
 Run (carrier) 140
a
 n/a
b
 
a
In methanol, a set of runs was completed with 70 mbar used for both load and run steps. For ICT01-2588 in 
Tris buffer containing 10% HP--CD as carrier, 300 mbar was used for both load and run steps. For fluorescein 
disodium salt in Tris buffer and Tris buffer containing 10%HP--CD as carrier, 140 mbar was used for both 
load and run steps. 
b
Sizing runs are automatically ended after the peak has passed the second window. 
 
 
  
Table(s)
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Table 2. Hydrodynamic radius for ICT01-2588 in DMSO and methanol as a function of 
concentration. n = 5 at each concentration. 
 
ICT01-2588 
conc (mg/mL) 
Rh (nm) 
DMSO Methanol 
1.00 1.174 ± 0.010  
0.50 1.266 ± 0.016 1.138 ± 0.067 
0.25 1.292 ± 0.035 1.006 ± 0.018 
0.125  1.270 ± 0.038 
 
 
 
  
3 
 
 
 
 
Table 3. Hydrodynamic radius and % area at window 1 for the non-aggregated form of 
ICT01-2588 over the concentration range 0.25 – 2.5 mg/mL in pH 8.4 Tris buffer with 10% 
HP--CD. Two HP--CD samples used: Sigma-Aldrich H107 (s1); Fisher Scientific 1038870 
(s2), and two wavelengths for detection 490 and 280 nm. n = 5 at each concentration. All 
sequences run from low to high concentration, except 4
th
 with HP--CD-s2 which was high to 
low. 
 ICT01-2588 concentration 
(mg/mL) 
 0.25 0.50 1.0 2.0 2.5 
Order in run 
sequence 
Wavelength 
(nm) 
HP--CD 
sample 
 Radius (nm)  
[% area] 
1
st
 490 s1   1.40±0.06 
[79±6] 
1.92±0.11 
[62±3] 
3.58±1.20 
[32±1] 
4.56±0.50 
[18±1] 
5.01±0.40 
[14±0] 
1
st
 280 s2   1.27±0.11
 
[100±0] 
1.29±0.02 
[100±0] 
1.23±0.01 
[88±3] 
1.34±0.02 
[72±1] 
1.35±0.02 
[73±1] 
2
nd
 280 s2   1.47±0.07
 
[58±9] 
2.24±0.22 
[40±6] 
1.28±0.01 
[91±4] 
1.26±0.03 
[76±2] 
1.35±0.03 
[79±1] 
3
rd
 490 s2   1.65±0.07
 
[62±9] 
2.72±0.12 
[46±5] 
2.94±0.09 
[42±2] 
1.27±0.08 
[77±1] 
1.42±0.04 
[81±1] 
4
th 
* 490 s2   1.68±0.06 
[60±5] 
2.42±0.06 
[47±3] 
2.59±0.09 
[40±3] 
6.82±0.64 
[24±1] 
3.29±0.41 
[32±8] 
*This sequence run from high to low concentration 
  
4 
 
 
  
Table 4. DLS measurements for Tris buffer with 10% HP--CD and solutions of ICT01-2588 
in Tris buffer with 10% HP--CD. Two HP--CD samples used: Sigma-Aldrich H107 (s1); 
Fisher Scientific 1038870 (s2). Viscosity 1.301 mPa s used in data processing. n=3 for each 
sample. 
. 
  Radius (nm) 
Cyclodextrin in Tris buffer ICT01-2588 concentration 
(mg/mL) 
z-ave Peak 1 
[percent] 
Peak 2 
[percent] 
10% HP--CD-s1 2.5  
 
728±17 
 
936 ± 65 
[98 ± 3] 
62 ± 108 
[2 ± 3] 
10% HP--CD-s2 2.5  
 
144±2 163 ± 2 
[100] 
- 
10% HP--CD-s2 0.25  141±2 157 ± 3 
[100] 
- 
10% HP--CD-s2 0 72±22 114 ± 2 
[58 ± 1] 
0.72 ± 0.01 
[4 2±1 ] 
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Fig. 1.  Structure of ICT01-2588: in the sequence of functional groups, those with arrows are 
potential binding sites for cyclodextrins. 
Fig. 2. Sizing records for ICT01-2588 in (a) DMSO at 1 mg/mL, load and drive pressure 140 
mbar and (b) methanol at 0.5 mg/mL, load and drive pressure 70 mbar. Wavelength 280 nm.  
 
Fig. 3. Photograph of samples of ICT01-2588 at nominal concentrations 1 mg/mL in water 
(left), Tris buffer (centre) and Tris buffer with 10% HP--CD-s2 (right). 
 
Fig. 4. Sizing records for ICT01-2588 at window 1 at concentrations 0.25, 0.5, 1, 2 and 2.5 
mg/mL.  
(a) Carrier medium Tris buffer with 10% HP--CD-s1. Wavelength 490 nm.  
(b) Carrier medium Tris buffer with 10% HP--CD-s2. Wavelength 280 nm.  
 
 Fig. 5. Sizing records and data fitting for ICT01-2588 0.5 mg/mL in Tris buffer with 10% 
HP--CD-s2. Wavelength 280 nm. Primary data (grey) and fit (black) using model with 
dispersive (dashed) and convective (dotted) components.  
 
 
Fig. 6. Schematic diagram of distance dependence of relative concentrations of monomer M,  
(solid grey) and aggregate, A, (stippled grey) at three time points: (a) on injection (t = 0); (b) 
at time to window 1 at 45 cm for monomer (t = 2.3 min); (c) at time to window 2 at 85 cm for 
monomer (t = 4.5 min). All concentations normalised to the maximum value at the particular 
time point, and correspond to the conditions of Fig. 5.   
 
Fig. 7. DLS data for (a) 2.5 mg/mL ICT01-2588 in Tris buffer with 10% HP--CD-s1, (b) 2.5 
mg/mL ICT01-2588 in Tris buffer with 10% HP--CD-s2. (c) Tris buffer with 10% HP--
CD-s2. In each case, results are presented as size distributions by intensity. Viscosity 1.301 
mPa s used in data processing.  
Figure(s)
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